CoChat

Amyloid imaging in dementias with atypical presentation

Open access
Wolk, David A., Price, Julie C., Madeira, Charles, Saxton, Judy A., Snitz, Beth E., Lopez, Oscar L., Mathis, Chester A., Klunk, William E., DeKosky, Steven T. · 2012 · Alzheimer's & Dementia
Cited by 49

The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.

Abstract

Background: With the potential emergence of disease specific therapies, an accurate biomarker of Alzheimer's Disease pathology is needed in cases in which the underlying etiology is uncertain. We explored the potential value of amyloid imaging in patients with atypical presentations of dementia. Methods: Twenty‐eight patients with atypical dementia underwent positron emission tomography imaging with the amyloid imaging tracer Pittsburgh compound B (PiB). Twenty‐six had [18F]fluoro‐2‐deoxy‐D‐glucose positron emission tomography scans. After extensive clinical evaluation, this group of patients generated considerable diagnostic uncertainty and received working diagnoses that included possible Alzheimer's disease (AD), focal dementias (e.g., posterior cortical atrophy [PCA]), or cases in which no clear diagnostic category could be determined (dementia of uncertain etiology). Patients were classified as PiB‐positive, PiB‐negative, or PiB‐intermediate, based on objective criteria. Anterior–posterior and left–right indices of PiB and [18F]fluoro‐2‐deoxy‐D‐glucose uptake were calculated to examine differences in distribution of amyloid pathology and metabolic changes associated with clinical phenotype. Results: Eleven patients (39%) were PiB positive, 16 were PiB negative (57%), and one (4%) was PiB intermediate. By diagnostic category, three of 10 patients (30%) with dementia of uncertain etiology, one of five (20%) with primary progressive aphasia, three of five (60%) with PCA, and four of seven (57%) with possible AD were PiB positive. Brain metabolism of both PiB‐positive and PiB‐negative patients was generally similar by phenotype, but appeared to differ from typical AD. PCA patients also appeared to differ in their relative distribution of PiB compared with typical AD, consistent with their atypical phenotype. Conclusions: AD pathology is frequently present in atypical presentations of dementia and can be identified by amyloid imaging. Clinical phenotype is more related to the pattern of cerebral hypometabolism than the presence/absence of amyloid pathology. These findings have diagnostic, prognostic, and therapeutic implications.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jalz.2011.07.003

Cites

13 of 13 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 13 references

Research works printed but not linked: 36

  1. 10.1111/j.1365-2796.2004.01380.x · DOI · Paper page
  2. 10.1111/j.1365-2796.2004.01388.x · DOI · Paper page
  3. 10.1007/s00401-007-0266-x · DOI · Paper page
  4. 10.1212/WNL.55.12.1854 · DOI · Paper page
  5. 10.1016/S0197-4580(00)00183-4 · DOI · Paper page
  6. 10.1002/ana.20009 · DOI · Paper page
  7. 10.1093/brain/awl178 · DOI · Paper page
  8. 10.1001/archneur.64.3.431 · DOI · Paper page
  9. 10.1016/j.neurobiolaging.2007.03.029 · DOI · Paper page
  10. 10.1002/ana.21598 · DOI · Paper page
  11. 10.1212/WNL.0b013e3181b23564 · DOI · Paper page
  12. WJJagust DBandy KChen NLFoster SMLandau CAMathis et al.The Alzheimer's Disease Neuroimaging Initiative positron emission tomography core. Alzheimers Dement;6:221–229. · DOI · Paper page
  13. 10.1159/000163927 · DOI · Paper page
  14. 10.1001/archneur.64.8.1140 · DOI · Paper page
  15. 10.1007/s00259-007-0523-1 · DOI · Paper page
  16. 10.1212/01.wnl.0000259035.98480.ed · DOI · Paper page
  17. 10.2967/jnumed.106.037762 · DOI · Paper page
  18. McKhann G, 1984, Clinical diagnosis of Alzheimer's disease: report of the NINCDS‐ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease, Neurology, 34, 285, 10.1212/WNL.34.7.939 · DOI · Paper page
  19. Mesulam MM, 2003, The core and halo of primary progressive aphasia and semantic dementia, Ann Neurol, 54, S11, 10.1002/ana.10569 · DOI
  20. 10.1212/01.wnl.0000196477.78548.db · DOI · Paper page
  21. 10.1212/WNL.51.6.1546 · DOI · Paper page
  22. Lopresti BJ, 2005, Simplified quantification of Pittsburgh Compound B amyloid imaging PET studies: a comparative analysis, J Nucl Med, 46, 1959
  23. 10.1038/sj.jcbfm.9600146 · DOI · Paper page
  24. 10.1109/23.873020 · DOI · Paper page
  25. Meltzer CC, 1999, Comparative evaluation of MR‐based partial‐volume correction schemes for PET, J Nucl Med, 40, 2053
  26. 10.1001/archneur.65.11.1509 · DOI · Paper page
  27. 10.1002/ana.20700 · DOI · Paper page
  28. 10.1212/01.WNL.0000140289.18472.15 · DOI · Paper page
  29. 10.1016/j.neurobiolaging.2007.02.016 · DOI · Paper page
  30. 10.1016/j.neuint.2009.02.017 · DOI
  31. 10.1097/00005072-199003000-00008 · DOI · Paper page
  32. Tenovuo O, 2008, Posterior cortical atrophy: a rare form of dementia with in vivo evidence of amyloid‐beta accumulation, J Alzheimers Dis, 15, 351, 10.3233/JAD-2008-15301 · DOI · Paper page
  33. 10.1212/WNL.40.3_Part_1.423 · DOI · Paper page
  34. Galton CJ, 2000, Atypical and typical presentations of Alzheimer's disease: a clinical, neuropsychological, neuroimaging and pathological study of 13 cases, Brain, 123, 484, 10.1093/brain/123.3.484 · DOI · Paper page
  35. 10.1016/S0197-4580(97)85095-6 · DOI
  36. 10.1002/ana.10825 · DOI · Paper page

Cited by

See all 49

Metadata

Authors
Wolk, D. A., Price, J. C., Madeira, C., Saxton, J. A., Snitz, B. E., Lopez, O. L., Mathis, C. A., Klunk, W. E., & DeKosky, S. T.
Venue
Alzheimer's & Dementia
Publisher
Wiley
Published
2012-01-30
Volume
8
Issue
5
Pages
389-398
ISSN
  • 1552-5260 (ISSN-L)
  • 1552-5279
OpenAlex
W2033010759
Cited by
49
References
13
FWCI
4.30
Type
journal article
Language
en
Open access
green
Funders
  • National Institutes of Health (P50 AG005133, P01 AG025204, K23 AG028018)
  • Pennsylvania Department of Health (SAP 4100027294)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Amyloid imaging in dementias with atypical presentation. https://app.cochat.ai/papers/10.1016/j.jalz.2011.07.003
The paper
Wolk, D. A., Price, J. C., Madeira, C., Saxton, J. A., Snitz, B. E., Lopez, O. L., Mathis, C. A., Klunk, W. E., & DeKosky, S. T. (2012). Amyloid imaging in dementias with atypical presentation. Alzheimer's & Dementia. https://doi.org/10.1016/j.jalz.2011.07.003

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.